VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
VolitionRx Limited has announced a conference call on May 15, 2026, to discuss its first quarter 2026 financial and operational results, as well as provide a business update. Key executives will host the call and a live audio webcast will be available. The company focuses on epigenetics and aims to develop cost-effective blood tests for detecting and monitoring diseases.
Conference call to take place on Friday, May 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev., May 11, 2026 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announces that it will host a conference call on Friday, May 15 at 8.30 a.m. U.S. Eastern Time to discuss…